Porous hollow fiber membrane and blood purification module

The porous hollow fiber membrane with an irregular inner surface and specific polymer composition addresses the efficiency and safety trade-offs in blood purification by maximizing inner surface area, enhancing membrane performance, and reducing blood retention and platelet adhesion, thereby improving blood purification efficiency and safety.

WO2024247796A1PCT designated stage expired Publication Date: 2024-12-05TORAY INDUSTRIES INC
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/018575
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-30
Filing Date
2024-05-21
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

In blood purification therapy, there is a trade-off between blood purification efficiency and the amount of blood taken out, as reducing the size of the blood purification module to minimize blood removal risks side effects also decreases the effective membrane area of porous hollow fiber membranes, leading to inefficiency and potential damage to blood cells.

Method used

A porous hollow fiber membrane with an irregular inner surface contour and specific diameter ratios is developed, maximizing the inner surface area per volume while maintaining safety, using a hydrophilic polymer and polysulfone-based amorphous polymer structure to enhance membrane performance and reduce blood retention.

Benefits of technology

The solution effectively increases the blood purification efficiency while minimizing the amount of blood taken out, ensuring safety by maximizing the inner surface area and reducing shear stress and platelet adhesion, thus stabilizing the membrane performance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024018575_05122024_PF_FP_ABST
    Figure JP2024018575_05122024_PF_FP_ABST
Patent Text Reader

Abstract

The purpose of the present invention is to provide a porous hollow fiber membrane capable of reducing the amount of blood drawn out while maintaining safety in, for example, blood purification application, by maximizing the inner surface area per volume of the porous hollow fiber membrane. The present invention provides a porous hollow fiber membrane which contains a hydrophilic polymer, and in which the shape of the outline of the inner surface in a cross-section perpendicular to the longitudinal direction is irregular, and IDi, which represents the diameter (μm) of an inscribed circle of the outline of the inner surface, and IDo, which represents the diameter (μm) of a circumscribed circle of the outline of the inner surface, satisfy the relationships of 95≤IDi≤1500, 100≤IDo≤1600, and 1.05≤IDo / IDi≤1.60.
Need to check novelty before this filing date? Find Prior Art

Description

Porous hollow fiber membrane and blood purification module

[0001] The present invention relates to a porous hollow fiber membrane and a blood purification module.

[0002] A hollow fiber membrane is partitioned into an inside and an outside of the hollow space by a membrane, and porous hollow fiber membranes having a microporous structure in particular are suitably used as separation membranes that separate substances into the inside and outside. For example, porous hollow fiber membranes are often used by filling the inside of blood purification modules in blood purification therapies such as those for treating renal failure, for the purpose of removing uremic toxins and waste products from the blood.

[0003] In blood purification therapy, if a large amount of blood is withdrawn from the patient's body at once, there is a risk of side effects such as decreased blood pressure and anemia. For this reason, it is necessary to keep the amount of blood withdrawn from the patient's body, i.e., the amount of blood taken out, as small as possible.

[0004] To reduce the amount of blood taken out, it is necessary to reduce the size of the blood purification module, but reducing the module size also reduces the amount of porous hollow fiber membrane that can be packed into it, which reduces the efficiency of blood purification.

[0005] Thus, there is a certain trade-off between blood purification efficiency and the amount of blood taken out. One way to overcome this trade-off is to increase the effective membrane area of ​​the porous hollow fiber membrane.

[0006] Known means for increasing the effective membrane area of ​​a porous hollow fiber membrane include, for example, a porous hollow fiber membrane that suppresses adhesion between hollow fibers (Patent Document 1) and a porous hollow fiber membrane with protrusions on the surface (Patent Document 2).

[0007] Patent No. 1783446 JP 63-21914 A

[0008] However, when a fin shape is provided on the outer surface of a hollow fiber as in Patent Document 1, the fiber bundle becomes bulky, reducing the number of hollow fibers that can be packed into a module, and there is a high possibility that the desired effective membrane area cannot be secured.

[0009] Furthermore, the protrusion shape as described in Patent Document 2 is a structure suitable for gas-liquid exchange applications such as artificial lungs, but when applied to blood purification applications, there is an extremely high risk of damaging blood cell components in the blood due to collisions with them.

[0010] Therefore, an object of the present invention is to provide a porous hollow fiber membrane that has a simple structure and can maximize the internal surface area per volume of the porous hollow fiber membrane.In particular, an object of the present invention is to provide a porous hollow fiber membrane for blood purification that can maximize the internal surface area per volume of the porous hollow fiber membrane and reduce the amount of blood carried out while maintaining safety in blood purification applications.

[0011] The present invention relates to: (1) a porous hollow fiber membrane containing a hydrophilic polymer, wherein the contour of the inner surface in a cross section perpendicular to the longitudinal direction is irregular, and wherein IDi is the diameter (μm) of the inscribed circle about the contour of the inner surface, and IDo is the diameter (μm) of the circumscribed circle about the contour of the inner surface, and IDi and IDo satisfy the relationships: 90 ≦ IDi ≦ 1500, 100 ≦ IDo ≦ 1600, and 1.05 ≦ IDo / IDi ≦ 1.60, respectively. (2) In the porous hollow fiber membrane containing a hydrophilic polymer, it is preferable that IDi and IDo satisfy the relationships: 90 ≦ IDi ≦ 1000, 100 ≦ IDo ≦ 1100, and 1.05 ≦ IDo / IDi ≦ 1.60, respectively. (3) In the porous hollow fiber membrane of (1) or (2) above, it is preferable that the contour of the inner surface has 6 to 40 convex portions. (4) In the porous hollow fiber membrane of (3) above, it is preferable that the convex portions are evenly distributed around the circumference of the circumscribed circle. (5) In the porous hollow fiber membrane of (1) or (2) above, it is preferable that the cross-sectional structure of a cross section perpendicular to the longitudinal direction exhibits an asymmetric structure with a dense inner surface. (6) In the porous hollow fiber membrane of (1) or (2) above, it is preferable that the porous hollow fiber membrane is mainly composed of an amorphous polymer. (7) In the porous hollow fiber membrane of (6) above, it is preferable that the amorphous polymer is a polysulfone-based polymer. (8) In the porous hollow fiber membrane of (1) or (2) above, it is preferable that the average membrane thickness is 10 to 80 μm. (9) In the porous hollow fiber membrane of (1) or (2) above, it is preferable that it is used for blood purification. (10) The present invention also relates to a porous hollow fiber membrane module having the porous hollow fiber membrane of (1) or (2) built in. (11) The present invention further relates to a porous hollow fiber membrane for blood purification, wherein the contour of the inner surface in a cross section perpendicular to the longitudinal direction is irregular, and when IDi is the diameter (μm) of the inscribed circle about the contour of the inner surface and IDo is the diameter (μm) of the circumscribed circle about the contour of the inner surface, IDi and IDo satisfy the relationships 90 ≦ IDi ≦ 1500, 100 ≦ IDo ≦ 1600, and 1.05 ≦ IDo / IDi ≦ 1.60, respectively.(12) In the porous hollow fiber membrane for blood purification described above in (11), it is preferable that the IDi and the IDo satisfy the following relationships: 90 ≦ IDi ≦ 1000, 100 ≦ IDo ≦ 1100, and 1.05 ≦ IDo / IDi ≦ 1.60, respectively. (13) The present invention also relates to a porous hollow fiber membrane module for blood purification incorporating the porous hollow fiber membrane for blood purification described above in (11) or (12).

[0012] According to the present invention, it is possible to maximize the internal surface area per volume of a porous hollow fiber membrane with a simple structure, and in blood purification applications, it is possible to significantly reduce the amount of blood carried out while maintaining both blood purification efficiency and safety.

[0013] FIG. 1 is a schematic diagram showing one embodiment of the annular slit shape of a double-tube spinneret for producing the hollow fiber membrane of the present invention.

[0014] The hollow fiber membrane can be produced, for example, by ejecting an injection liquid or injection gas from the inner circular tube of a double-tube spinneret and discharging the spinning dope from the outer slit. In this case, the structure of the hollow fiber membrane can be controlled by appropriately adjusting the spinning dope composition, the type of injection liquid or injection gas, and the temperature, etc.

[0015] The porous hollow fiber membrane of the present invention (hereinafter referred to as the "hollow fiber membrane of the present invention") is characterized in that the outline of the inner surface in a cross section perpendicular to the longitudinal direction is irregular. Here, "irregular" refers to a shape other than a perfect circle. The irregular shape may be a shape that maintains symmetry, such as line symmetry or point symmetry, or may be an asymmetric shape.

[0016] The hollow fiber membrane of the present invention is characterized in that, when IDi is the diameter (μm) of the inscribed circle about the outline of the inner surface and IDo is the diameter (μm) of the circumscribed circle about the outline of the inner surface, IDi and IDo satisfy the relationships 90≦IDi≦1500, 100≦IDo≦1600, and 1.05≦IDo / IDo≦1.60, respectively.

[0017] When the irregular shape is a symmetrical shape, the inscribed circle is a circle inscribed in the contour of the irregular shape, and the circumscribed circle is a circle circumscribed around the contour of the irregular shape. Specifically, the inscribed circle or circumscribed circle can be determined by observing a cross section perpendicular to the longitudinal direction of the hollow fiber membrane, selecting the vertices of the irregularities in the contour of the inner surface of the hollow fiber membrane, and drawing an approximate circle around those vertices.

[0018] On the other hand, when the irregular shape is asymmetric, the inscribed circle and circumscribed circle are defined as follows: The inscribed circle is a circle that is inscribed at least two points in the curve that defines the outline of the inner surface of the hollow fiber membrane, exists only in the hollow portion of the hollow fiber membrane, and has the largest possible diameter within a range in which the circumference of the inscribed circle and the curve that defines the outline of the inner surface of the hollow fiber membrane do not intersect. The circumscribed circle is a circle that is circumscribed at least two points in the curve that defines the outline of the inner surface of the hollow fiber membrane, exists only outside the inner surface of the hollow fiber membrane, and has the smallest possible diameter within a range in which the circumference of the circumscribed circle and the outline of the inner surface of the hollow fiber membrane do not intersect.

[0019] IDi must be 90 μm or more, preferably 120 μm or more, and more preferably 150 μm or more, in order to reduce shear stress of fluids such as blood flowing through the hollow fiber membrane and suppress activation of blood cell components, etc. On the other hand, IDi must be 1500 μm or less, preferably 1000 μm or less, further preferably 500 μm or less, and more preferably 300 μm or less, in order to improve removal efficiency by diffusion.

[0020] For the same reason, IDo must be 100 μm or more, preferably 120 μm or more, and more preferably 150 μm or more. On the other hand, IDo must be 1600 μm or less, but is preferably 1100 μm or less, further preferably 600 μm or less, and more preferably 400 μm or less.

[0021] The value obtained by dividing IDo by IDi, i.e., "IDo / IDi," must be 1.05 or more, preferably 1.08 or more, and more preferably 1.10 or more, in order to increase the effective membrane area of ​​the inner surface of the hollow fiber membrane. On the other hand, in order to suppress platelet adhesion to the recesses on the inner surface, the value must be 1.60 or less, preferably 1.50 or less, and more preferably 1.40 or less.

[0022] The difference between IDo and IDi is preferably 5 μm or more, more preferably 10 μm or more, in order to increase the effective membrane area of ​​the inner surface of the hollow fiber membrane, while the difference is preferably 100 μm or less, more preferably 80 μm or less, in order to suppress adhesion of platelets and the like to the recesses on the inner surface.

[0023] When the region surrounded by the inscribed circle is designated IAi and the region surrounded by the circumscribed circle is designated IAo, the cross-sectional area ratio R of the porous hollow fiber membrane in the region IAm obtained by subtracting IAi from IAo is preferably 0.35 to 0.75. To increase the effective membrane area of ​​the inner surface of the hollow fiber membrane, the cross-sectional area ratio R is more preferably 0.40 or more. On the other hand, to prevent blood from accumulating in recesses on the inner surface, the cross-sectional area ratio R is more preferably 0.60 or less.

[0024] The hollow fiber membrane of the present invention preferably has 6 to 40 convex portions in the outline of the inner surface. The concave and convex portions in the outline of the inner surface refer to portions that are convex toward the center of a cross section perpendicular to the longitudinal direction of the hollow fiber membrane, and concave portions refer to portions that are concave toward the center of the cross section. The number of convex portions in the outline of the inner surface is preferably 6 or more, more preferably 8 or more, in order to increase the effective membrane area of ​​the hollow fiber inner surface. On the other hand, the number is preferably 40 or less, more preferably 36 or less, in order to prevent adhesion or contact between the convex portions or from the viewpoint of limitations on the processing accuracy of the spinneret.

[0025] The convex portions are preferably evenly distributed on the circumference of the circumscribed circle. The even distribution of the convex portions can suppress unevenness in the structure of the hollow fiber membrane, stabilizing the performance of the hollow fiber membrane. Here, "evenly distributed" means that each convex portion has approximately point symmetry. For example, the coefficient of variation for a group of measured values ​​of the distance between the vertices of adjacent convex portions is preferably 0.3 or less, and more preferably 0.2 or less.

[0026] The hollow fiber membrane of the present invention preferably has an average membrane thickness of 10 to 80 μm. Here, "average membrane thickness" refers to the average value of the maximum and minimum membrane thicknesses of the hollow fiber membrane. In order to ensure membrane strength that can withstand the operating pressure in blood purification applications, etc., the average membrane thickness of the hollow fiber membrane is preferably 10 μm or more, more preferably 20 μm or more. On the other hand, in order to reduce permeation resistance, the average membrane thickness is preferably 80 μm or less, more preferably 60 μm or less.

[0027] The degree of irregularity of the hollow fiber membrane of the present invention is preferably 1.05 to 2.00. Here, "degree of irregularity" refers to the value obtained by dividing the perimeter of the inner surface in a cross section perpendicular to the longitudinal direction of the hollow fiber membrane by the average value of IDi and IDo. The degree of irregularity of the hollow fiber membrane is preferably 1.05 or more, more preferably 1.10 or more, in order to increase the effective membrane area of ​​the inner surface of the hollow fiber. On the other hand, in order to suppress blood retention, etc., the degree of irregularity is preferably 2.00 or less, more preferably 1.80 or less.

[0028] The hollow fiber membrane of the present invention has a large number of pores inside. The average pore radius of the internal pores is preferably 1.0 nm or more, more preferably 1.5 nm or more, in order to improve permeability. On the other hand, when used for blood purification, for example, in order to prevent useful substances in blood, such as antibodies and albumin, from being removed from the blood, the average pore radius is preferably 90 nm or less, more preferably 60 nm or less.

[0029] The permeability of a hollow fiber membrane is greatly affected by the porosity of the inner surface. In the hollow fiber membrane of the present invention, in order to widen the flow path through which substances can pass and reduce permeation resistance, the porosity of the inner surface is preferably 2% or more, more preferably 3% or more, and even more preferably 4% or more. On the other hand, in order to more easily control the pore size, the porosity of the inner surface is preferably 30% or less, more preferably 25% or less. The porosity of the inner surface can be calculated by observing the surface of the hollow fiber membrane with a scanning electron microscope (SEM) and analyzing the image. The observation magnification and conditions can be determined appropriately depending on the state of the surface pores. For example, an image observed at a magnification of 50,000 times can be image-processed over an arbitrary 2.5 μm × 1.9 μm area, and the membrane structure and pore portions can be binarized. The area percentage of the pore portion relative to the measured area can be calculated to determine the porosity.

[0030] Hollow fiber membranes have cross-sectional structures perpendicular to the longitudinal direction, including a symmetric structure in which the pore size does not substantially change in the membrane thickness direction, and an asymmetric structure in which the pore size changes continuously or discontinuously. The hollow fiber membrane of the present invention preferably exhibits an internally dense asymmetric structure in which the pore size is smaller on the inside than on the outside in the membrane thickness direction in a cross-section perpendicular to the longitudinal direction. A hollow fiber membrane exhibiting an asymmetric structure can reduce the layer of small pores that contribute to size exclusion, thereby enabling improved water permeability while reducing water permeation resistance. Furthermore, for hollow fiber membranes used for blood purification, since blood components are often passed through the hollow fibers, it is preferable for the membrane to exhibit an internally dense asymmetric structure in order to suppress fouling on the inner surface of the hollow fibers.

[0031] The main component of the hollow fiber membrane of the present invention is preferably an amorphous polymer. Here, "amorphous polymer" refers to a polymer that does not crystallize, more specifically, a polymer that does not exhibit an exothermic peak due to crystallization in measurement with a differential scanning calorimeter. The "main component of the hollow fiber membrane" refers to the component that is most frequently detected when the hollow fiber membrane is analyzed by infrared spectroscopy or mass spectrometry. The method for component analysis is not particularly limited, but infrared spectroscopy, mass spectrometry, etc. are preferably used.

[0032] Examples of amorphous polymers include polystyrene, polycarbonate, polyacrylonitrile, polymethyl methacrylate, polyvinyl chloride, and polysulfone, with polysulfone being preferred because the pore size is easy to control.

[0033] Examples of polysulfone include Udel (registered trademark) polysulfone P-1700 and P-3500 (manufactured by Solvay), and Ultrason (registered trademark) S3010 or S6010 (manufactured by BASF).

[0034] For example, the shape of the outlet of the double-tube nozzle is important for producing the hollow fiber membrane of the present invention. For example, by making the shape of the inner frame 3 of the double-tube nozzle irregular as shown in Figure 1, it is possible to obtain a hollow fiber membrane of the present invention having an irregular inner surface contour.

[0035] The hollow fiber membrane manufacturing method of the present invention may include, for example, a manufacturing method comprising a discharge step of discharging the spinning dope through a slit formed in a double-tube spinneret, a cooling step of passing the dope through a dry section consisting of a gas phase, and a solidification step of solidifying the dope in a coagulation bath after the cooling step. When phase separation is induced by heat, a method of rapid cooling in the solidification step may be used. When phase separation is induced by a poor solvent, a method of discharging a poor solvent for the main component of the spinning dope as an injection liquid and then solidifying the dope in a coagulation bath containing a poor solvent for the main component may be used. When phase separation is induced by a poor solvent, the poor solvent is supplied in the membrane thickness direction by diffusion, resulting in a difference in the concentration of the poor solvent in the membrane thickness direction, which tends to result in an asymmetric structure of the hollow fiber membrane. Therefore, it is preferable that the coagulation solution containing the poor solvent contacts the spinning dope in the dry section. In this case, adding a good solvent to the coagulation solution to adjust the concentration of the poor solvent changes the coagulation properties, allowing the surface pore size to be adjusted while maintaining spinnability.

[0036] Here, the term "poor solvent" refers to a solvent that does not dissolve the main component of the spinning dope at the temperature of the double-tube spinneret in the extrusion process. When the main component of the spinning dope is polysulfone, water is a preferred poor solvent. Note that N,N-dimethylacetamide, for example, is a preferred good solvent. The concentration of the good solvent is preferably 40 to 80% by mass, more preferably 50 to 70% by mass.

[0037] The temperature of the double-tube spinneret in the extrusion process affects the viscosity of the spinning dope and the phase separation behavior of the hollow fiber membrane. Generally, the higher the spinneret temperature, the greater the water permeability and molecular weight cutoff of the resulting porous membrane. However, to maintain spinnability, the double-tube spinneret temperature is preferably 90°C or lower. On the other hand, to prevent moisture from adhering to the double-tube spinneret due to condensation, the double-tube spinneret temperature is preferably 20°C or higher.

[0038] The temperature of the coagulation bath in the solidification step is preferably in the range of 20 to 90°C.

[0039] After the solidification step, the hollow fiber membrane is preferably passed through a water washing bath to remove residual solvent, etc. The temperature of the water washing bath is preferably 60 to 90°C to increase the washing efficiency.

[0040] The hollow fiber membrane may be further dried by, for example, drying with hot air, drying with microwaves, or drying under reduced pressure, with hot air being preferred.

[0041] When the hollow fiber membrane is dried, crimping is preferred because it improves the flow of dialysate when the membrane is incorporated into a module. The crimp pitch is preferably in the range of 5 to 30 mm, and the amplitude is preferably in the range of 0.2 to 3 mm.

[0042] If the hollow fiber membrane is not dried, it may be impregnated with a moisturizing component to maintain the pore size. The impregnation with the moisturizing component is preferably carried out after passing through a water washing bath. Examples of the moisturizing component include glycerin and an aqueous solution thereof.

[0043] The porous hollow fiber membrane module of the present invention contains the hollow fiber membrane of the present invention built in.

[0044] For example, when used for blood purification, a porous hollow fiber membrane module can be produced by bundling the required number of hollow fiber membranes of the present invention cut to an appropriate length, placing them in a cylindrical case, potting both ends with a potting agent, cutting both ends so that the ends of the hollow fiber membranes are open, and then attaching headers to both ends. In order to fill the potting agent uniformly, it is preferable to inject the potting agent while rotating the module containing the hollow fiber membranes in a centrifuge.

[0045] Blood volume per membrane area of ​​hollow fiber membrane (cm 3 / mm 2 ) is preferably 1.0 to 1.9, and more preferably 1.1 to 1.8. By setting the blood volume per membrane area to 1.9 or less, it is possible to improve blood purification efficiency while reducing the amount of blood taken out, contributing to stabilizing the patient's circulatory dynamics. On the other hand, by setting the blood volume per membrane area to 1.0 or more, it is possible to avoid an increase in the linear velocity of blood inflow due to an excessive reduction in the diameter of the hollow fiber double-tube nozzle inner frame 3, and to suppress the activation of blood cell components, etc.

[0046] The hollow fiber membrane of the present invention and a blood purification module incorporating the hollow fiber membrane obtained by the production method of the present invention are used for blood purification in an artificial kidney or a blood component separator, etc.

[0047] Therefore, it is preferable that the hollow fiber membrane has excellent biocompatibility. Here, "excellent biocompatibility" means, for example, that when human blood is brought into contact with the inner surface of the hollow fiber, the number of platelets that adhere is small. If the number of platelets that adhere is small, the platelets are not activated, and inflammatory reactions due to the release of platelet activating factors and the like can be suppressed. When human blood is brought into contact with the hollow fiber membrane, the number of platelets that adhere is 20 / (5.2 × 10 3 μm 2 ) or less, and 15 pieces / (5.2 × 10 3 μm 2 ) or less is more preferable, and 10 pieces / (5.2 × 10 3 μm 2 ) The following is even more preferred.

[0048] The hollow fiber membrane of the present invention preferably contains a hydrophilic polymer. The hydrophilic polymer in the membrane-forming solution acts as a pore-forming agent by partially eluting, and the remaining hydrophilic polymer is expected to improve the water permeability and hydrophilicity of the resulting hollow fiber membrane. In the present invention, a hydrophilic polymer refers to a polymer having a solubility of 1 g or more in 100 g of water at 20°C. The hydrophilic polymer is not particularly limited, but commonly used examples include polyethylene glycol, polyvinyl alcohol, polyvinylpyrrolidone, carboxymethyl cellulose, polypropylene glycol, and polyethyleneimine. Among these, when a polysulfone-based polymer is used as the amorphous polymer, polyvinylpyrrolidone is preferably used from the viewpoints of compatibility and safety. The location of the hollow fiber membrane containing the hydrophilic polymer is not limited; it may be unevenly distributed on the surface or may be contained throughout the membrane. Furthermore, the method for producing a hollow fiber membrane containing a hydrophilic polymer is not particularly limited, but common methods include adding the hydrophilic polymer to a membrane-forming solution for the hollow fiber membrane, or immersing the formed hollow fiber membrane in a solution containing the hydrophilic polymer to impart the hydrophilic polymer to the surface of the hollow fiber membrane. When added to the membrane-forming solution, the optimal amount varies depending on the type and intended performance, but is preferably 1% by mass or more, and more preferably 20% by mass or less. The hydrophilic polymer may be used alone or in combination of two or more types. The inclusion of a hydrophilic polymer can be determined, for example, by detecting a peak derived from the hydrophilic polymer component using X-ray electron spectroscopy.

[0049] In order to improve the biocompatibility of the hollow fiber membrane or to suppress protein fouling, a specific polymer or the like may be present on the surface of the hollow fiber membrane, provided that the performance of the hollow fiber membrane is not changed. An example of a mode in which a polymer is present on the surface of the hollow fiber membrane is to coat the surface of the hollow fiber membrane with the polymer. Examples of methods for coating the surface of the hollow fiber membrane with the polymer include adding the polymer to the spinning dope, adding the polymer to the injection liquid in the discharge step, or coating the surface of the hollow fiber membrane with the polymer after it has been formed. Water is preferably used as the solution for coating.

[0050] Furthermore, when a compound having an ester group is present on the surface of the hollow fiber membrane, adhesion of proteins and platelets is suppressed. Therefore, examples of the polymer include vinyl carboxylate esters such as vinyl acetate, acrylic esters such as methyl acrylate and methoxyethyl acrylate, methacrylic esters such as methyl methacrylate, ethyl methacrylate and hydroxyethyl methacrylate, and polyvinyl alcohol with a saponification degree of less than 99%, vinylpyrrolidone-vinyl acetate copolymer, vinylpyrrolidone-vinyl caprolactam copolymer, and vinylpyrrolidone-vinyl alcohol copolymer, with vinylpyrrolidone-vinyl acetate copolymer being preferred.

[0051] The polymer used for coating is preferably immobilized on the surface of the hollow fiber membrane by chemical bonding. Examples of methods for immobilizing the polymer by chemical bonding include a method in which the polymer is brought into contact with the hollow fiber membrane and then irradiated with radiation, and a method in which reactive groups such as amino groups and carboxyl groups are introduced into both the coating polymer and the surface of the hollow fiber membrane to be immobilized, and then the two are reacted with each other.

[0052] The hollow fiber membrane of the present invention has a wide variety of applications, including filters for various fluids, regardless of whether they are gas or liquid, heat insulating materials, sound absorbing materials, shock absorbing materials, cell culture substrates, carriers for regenerative medicine, and bioprocessing applications. Furthermore, in medical applications, the membrane is preferably used for removing pathogenic proteins, bacteria, viruses, endotoxins, sugar chains, autoantibodies, immune complexes, free light chains, potassium, bilirubin, bile acids, creatinine, phosphorus compounds, drugs, and the like from blood, plasma, and body fluids, and is particularly preferably used for blood purification. Furthermore, in water treatment applications, the membrane is preferably used for removing humic substances, metal corrosion products, and the like.

[0053] When the hollow fiber membrane module of the present invention is used for medical purposes, prior sterilization is required. Radiation sterilization is often used because it has low residual toxicity and is simple. Examples of radiation used for radiation sterilization include α-rays, β-rays, γ-rays, X-rays, ultraviolet rays, and electron beams. However, γ-rays and electron beams are preferred because they have low residual toxicity and are simple. Furthermore, if the hollow fiber membrane contains a polymer having a hydrophilic group, there is a risk that the polymer will subsequently be eluted from the hollow fiber membrane. However, a crosslinking reaction caused by irradiation with radiation can immobilize such a polymer on the inner surface of the hollow fiber membrane. To ensure sterilization while preventing decomposition of the polymer contained in the hollow fiber membrane, the irradiation dose is preferably 15 kGy to 100 kGy.

[0054] The water permeability of the hollow fiber membrane of the present invention is set to 100 to 3000 (mL / hr / m) in order to ensure sufficient permeability and filtration rate while suppressing the risk of leakage of useful proteins and the like and irritation to blood cell components. 2 / mmHg), and 200 to 2500 (mL / hr / m 2 The water permeability (UFR) can be calculated by the following formula (1): UFR (mL / hr / m 2 / mmHg) = Qw / (P × T × A) (1) where Qw: filtration volume (mL), T: effusion time (hr), P: pressure (mmHg), A: inner surface area of ​​hollow fiber membrane (m 2 )

[0055] (1) Observation of the cross section of the hollow fiber membrane Eight randomly selected hollow fiber membranes were used as samples, and each was cut at a random position to expose a cross section perpendicular to the longitudinal direction. When measuring hollow fiber membranes packed in a module, the module was disassembled and eight membranes were randomly removed. Each cross section was observed with a digital microscope (RH-2000; manufactured by HIROX Corporation), and the diameter of the inscribed circle for the outline of the inner surface and the diameter of the circumscribed circle for the outline of the inner surface were measured, and the respective average values ​​were calculated as IDi and IDo.

[0056] The average membrane thickness of the hollow fiber membranes was determined by observing each cross section with a digital microscope (RH-2000; manufactured by HIROX Corporation), measuring the membrane thickness at 60 points evenly spaced in the circumferential direction, and calculating the maximum and minimum values. The maximum and minimum values ​​were calculated for eight hollow fiber membranes, and the average values ​​were calculated as the maximum and minimum membrane thicknesses. The average of these two values ​​was defined as the average membrane thickness of the hollow fiber membranes.

[0057] The number of irregularities per circumference is calculated by counting each point at which the inclination in the circumferential direction changes on the contour of the inner surface as one.

[0058] The cross-sectional area ratio R of the hollow fiber membrane in the region IAm, which is the region IAo surrounded by the circumscribed circle minus the region IAi surrounded by the inscribed circle, was calculated using the following formula (2) by measuring the area IAs of the hollow portion by tracing the outline of the inner surface of the hollow fiber membrane. Cross-sectional area ratio R = (IAo - IAs) / IAm (2) (2) Measurement of water permeability Forty hollow fiber membranes were bundled together and packed into a cylindrical case having a diameter of 5 mm and a length of 17 cm. Both ends were potted with an epoxy resin-based chemical reaction adhesive (manufactured by Konishi Co., Ltd.; "Quick Mender" (registered trademark)). Both ends were cut to open the ends of each hollow fiber membrane, thereby producing a blood purification module. The inside of the blood purification module was then washed with distilled water for 30 minutes. Thereafter, a water pressure of 100 mmHg was applied to the inside of the hollow fiber membrane, and the amount of water permeating per unit time and flowing out to the outside of the hollow fiber membrane was measured. In this case, it was determined that the amount of water permeating was preferably 4 to 30 mL, and more preferably 5 to 20 mL.

[0059] (3) Measurement of platelet adhesion count. Double-sided tape was attached to a circular 18 mm diameter polystyrene plate, and a hollow fiber membrane was fixed thereto. The fixed hollow fiber membrane was cut into a semi-cylindrical shape with a single-edged blade to expose the inner surface of the hollow fiber membrane. The circular plate was attached to a cylindrically cut "Falcon" (registered trademark) tube (18 mm diameter, No. 2051, 3 cm long) so that the side with the fixed hollow fiber membrane was facing the inside of the tube, and the gap was filled with parafilm. The tube was washed with saline and then filled with saline. Blood from a healthy adult was collected, and immediately added with heparin sodium injection (manufactured by AY Pharmaceuticals Co., Ltd.) as an anticoagulant to a concentration of 100 U / mL. 1.0 mL of the blood was added to the tube within 30 minutes after collection, and the tube was shaken at 37°C for 1 hour at 700 rpm. The tube was then washed with 10 mL of physiological saline, and 1 mL of 2.5% by volume glutaraldehyde physiological saline was added and allowed to stand to immobilize the blood components on the hollow fiber membrane. After 1 hour, the hollow fiber membrane was removed and washed with 20 mL of distilled water. The washed hollow fiber membrane was dried under reduced pressure at room temperature (25°C) and 0.5 Torr for 10 hours. This hollow fiber membrane was attached to the sample stage of a scanning electron microscope with double-sided tape. A thin film of Pt-Pd was then formed on the inner surface of the hollow fiber membrane by sputtering, and this was used as a sample.

[0060] The surface of the sample was observed at a magnification of 1,500 times using a scanning electron microscope (Hitachi High-Tech Fielding Corporation; S-3000). 3 μm 2 The number of adhered platelets was counted at 20 randomly selected locations, and the average value was taken as the number of adhered platelets.

[0061] (4) Calculation of Membrane Area and Blood Volume The membrane area per unit length was calculated using the following formula (3): Membrane area = (IDi + IDo) / 2 / 1000000 × π × Degree of irregularity (3) The blood volume per unit length was calculated using the following formula (4): Blood volume = [(IDi + IDo) / 2 / 10000]^2 × π (4) Example 1 16% by mass of polysulfone (manufactured by Solvay; "Udel" (registered trademark) P-3500), 4% by mass of polyvinylpyrrolidone (manufactured by International Special Products; hereinafter abbreviated as ISP K30), and 2% by mass of polyvinylpyrrolidone (manufactured by ISP K90) were added to a mixed solvent of 77% by mass of N,N-dimethylacetamide and 1% by mass of water, and the mixture was heated and dissolved at 90°C for 6 hours to obtain a spinning dope. This spinning dope was discharged from the annular slit (between the outer frame 1 and the inner frame 3) of the double-tube spinneret having the shape shown in FIG. 1 . The outer diameter of the annular slit (the diameter of the outer frame 1 of the double-tube spinneret) was 0.62 mm, the diameter of the circumscribing circle 2 of the recess of the inner frame 3 of the double-tube spinneret was 0.45 mm, and the diameter of the inscribing circle 4 of the protrusion of the inner frame 3 of the double-tube spinneret was 0.25 mm. As the injection liquid, a solution consisting of 63 mass% N,N-dimethylacetamide and 37 mass% water was discharged from the inner tube. The spinneret was kept at 50°C. The discharged spinning dope passed through a 350 mm dry section with a dew point of 26°C (temperature 30°C, humidity 80%) in 0.7 seconds, then introduced into a water bath (coagulation bath) at 40°C to solidify, and then taken up at a speed of 30 m / min with a first roller outside the coagulation bath, washed with water in a 60°C water bath, and wound up. By adjusting the discharge rates of the spinning dope and the injection solution, porous hollow fiber membranes with irregularly shaped inner surfaces were obtained. The hollow fiber diameter and water permeability of the obtained membranes were measured, and the results are shown in Table 1.

[0062] In addition, 40 of the resulting hollow fibers were packed into a case approximately 5 mm in diameter and 17 cm long. Both ends of the hollow fibers were fixed to the ends of the case by potting, and a portion of the end of the potting material was cut to open both sides of the hollow fiber membranes at both ends. Header modules were attached to both sides of the case to form a module. A 0.1% by mass aqueous solution of vinylpyrrolidone / vinyl acetate (6 / 4) random copolymer (BASF; "KOLLIDON" (registered trademark) VA64) was introduced into the module through the inlet for the liquid to be treated, which communicated with the hollow section of the module, for 2 minutes, and then irradiated with gamma rays to obtain a hollow fiber membrane module. The resulting hollow fiber membrane module was disassembled, and the hollow fiber membranes were removed and used to measure the number of adherent platelets. The results are shown in Table 1.

[0063] [Example 2] A hollow fiber membrane and a hollow fiber membrane module were obtained in the same manner as in Example 1, except that the die was kept at 30° C. The evaluation results of the obtained hollow fiber membrane and hollow fiber membrane module are shown in Table 1.

[0064] Example 3 A hollow fiber membrane and a hollow fiber membrane module were obtained in the same manner as in Example 1, except that a solution consisting of 50% by mass of N,N-dimethylacetamide and 50% by mass of water was used as the injection liquid. The evaluation results of the obtained hollow fiber membrane and hollow fiber membrane module are shown in Table 1.

[0065] Example 4 A hollow fiber membrane and a hollow fiber membrane module were obtained in the same manner as in Example 1, except that the outer diameter of the annular slit was 0.45 mm, the diameter of the circumscribing circle 2 of the recessed portion of the inner frame 3 of the double-tube nozzle was 0.35 mm, the diameter of the inscribing circle 4 of the protruding portion of the inner frame 3 of the double-tube nozzle was 0.25 mm, and a solution consisting of 60% by mass of N,N-dimethylacetamide and 40% by mass of water was used as the injection liquid. The evaluation results of the obtained hollow fiber membrane and hollow fiber membrane module are shown in Table 1.

[0066] Example 5 A hollow fiber membrane and a hollow fiber membrane module were obtained in the same manner as in Example 1, except that the number of convex portions of the annular slit was 20, the outer diameter was 0.62 mm, the diameter of the circumscribing circle 2 of the concave portions of the inner frame 3 of the double-tube nozzle was 0.39 mm, the diameter of the inscribing circle 4 of the convex portions of the inner frame 3 of the double-tube nozzle was 0.34 mm, and a solution consisting of 60 mass % N,N-dimethylacetamide and 40 mass % water was used as the injection liquid. The evaluation results of the obtained hollow fiber membranes and hollow fiber membrane module are shown in Table 1.

[0067] Comparative Example 1 A hollow fiber membrane and a hollow fiber membrane module were obtained in the same manner as in Example 1, except that a circular double-tube spinneret with an annular slit having an outer diameter of 0.35 mm and an inner diameter of 0.25 mm was used. The evaluation results of the obtained hollow fiber membranes and hollow fiber membrane module are shown in Table 1.

[0068] Comparative Example 2 A hollow fiber membrane and a hollow fiber membrane module were obtained in the same manner as in Example 1, except that the die was kept at 75° C. The evaluation results of the obtained hollow fiber membrane and hollow fiber membrane module are shown in Table 1.

[0069] Comparative Example 3 A hollow fiber membrane and a hollow fiber membrane module were obtained in the same manner as in Example 1, except that a solution consisting of 42 mass % N,N-dimethylacetamide and 58 mass % water was used as the injection liquid. The evaluation results of the obtained hollow fiber membrane and hollow fiber membrane module are shown in Table 1.

[0070]

[0071] 1 outer frame of double pipe nozzle 2 circumscribing circle of recess of inner frame 3 of double pipe nozzle 3 3 inner frame of double pipe nozzle 4 inscribing circle of protrusion of inner frame 3 of double pipe nozzle 5 pipe from which grout is discharged 6 grout discharge portion

Claims

1. A porous hollow fiber membrane containing a hydrophilic polymer, wherein the contour of an inner surface in a cross section perpendicular to the longitudinal direction is irregular, and when IDi is the diameter (μm) of an inscribed circle about the contour of the inner surface and IDo is the diameter (μm) of a circumscribed circle about the contour of the inner surface, IDi and IDo respectively satisfy the relationships: 90≦IDi≦1500, 100≦IDo≦1600, and 1.05≦IDo / IDi≦1.

60.

2. The porous hollow fiber membrane according to claim 1, wherein the IDi and the IDo satisfy the following relationships: 90≦IDi≦1000, 100≦IDo≦1100, and 1.05≦IDo / IDi≦1.60, respectively.

3. The porous hollow fiber membrane according to claim 1 or 2, wherein the inner surface profile has 6 to 40 projections.

4. The porous hollow fiber membrane according to claim 3, wherein the convex portions are evenly spaced on the circumference of the circumscribing circle.

5. The porous hollow fiber membrane according to claim 1 or 2, wherein the cross-sectional structure in a cross section perpendicular to the longitudinal direction exhibits an inner dense asymmetric structure.

6. The porous hollow fiber membrane according to claim 1 or 2, which is mainly composed of an amorphous polymer.

7. The porous hollow fiber membrane according to claim 6, wherein the amorphous polymer is a polysulfone-based polymer.

8. The porous hollow fiber membrane according to claim 1 or 2, having an average membrane thickness of 10 to 80 μm.

9. The porous hollow fiber membrane according to claim 1 or 2, which is used for blood purification.

10. A porous hollow fiber membrane module having the porous hollow fiber membrane according to claim 1 or 2 built in.

11. A porous hollow fiber membrane for blood purification, wherein the contour of an inner surface in a cross section perpendicular to the longitudinal direction is irregular, and when IDi is the diameter (μm) of an inscribed circle about the contour of said inner surface and IDo is the diameter (μm) of a circumscribed circle about said contour of said inner surface, IDi and IDo respectively satisfy the relationships: 90≦IDi≦1500, 100≦IDo≦1600, and 1.05≦IDo / IDi≦1.

60.

12. The blood purification porous hollow fiber membrane according to claim 11, wherein the IDi and the IDo respectively satisfy the relationships: 90≦IDi≦1000, 100≦IDo≦1100, and 1.05≦IDo / IDi≦1.

60.

13. A porous hollow fiber membrane module for blood purification, having the porous hollow fiber membrane according to claim 11 or 12 built in.

Citation Information

Patent Citations

  • Sofa

    JP1783446S

  • Porous hollow yarn membrane of modified cross section

    JP1988021914A

  • Hollow fiber made of synthetic polymer and heat transfer device using same

    JP1981000308A

  • Permselective hollow yarn membrane

    JP1984062304A

  • Hollow fiber membrane for separation and manufacture thereof

    JP1999179174A